August 2024 Federal Circuit Newsletter(Japanese) August 2024 Federal Circuit Newsletter (Chinese) Specify the Steps of Information Manipulation or Lose under § 101 In Mobile Acuity Ltd. v. Blippar Ltd., Appeal…
July 2024 Federal Circuit Newsletter (Japanese) July 2024 Federal Circuit Newsletter (Chinese) “Mere Vulnerability” to an Invalidity Challenge Insufficient to Defeat Preliminary Injunction In Natera, Inc v. Neogenomics Laboratories,…
June 2024 Federal Circuit Newsletter (Japanese) June 2024 Federal Circuit Newsletter (Chinese) Reliably Determining Reasonable Royalty Rates from Lump Sum Licenses In Ecofactor, Inc. V. Google LLC, Appeal No….
May 2024 Federal Circuit Newsletter (Japanese) May 2024 Federal Circuit Newsletter (Chinese) Infringement Judgement is Only Final when there’s Nothing Left to Do but Execute In Packet Intelligence LLC v….
April 2024 Federal Circuit Newsletter (Japanese) April 2024 Federal Circuit Newsletter (Chinese) Obviousness Analysis Does Not Consider Unclaimed Limitations In Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals Usa, Inc., Appeal No….
March 2024 Federal Circuit Newsletter (Japanese) March 2024 Federal Circuit Newsletter (Chinese) Defining Indefiniteness: When Are Claim Limitations Contradictory? In Maxell, Ltd., v. Amperex Technology Limited, Appeal No. 23-1194,…
February 2024 Federal Circuit Newsletter (Japanese) February 2024 Federal Circuit Newsletter (Chinese) The Outcome of the PTAB’s Analysis May Determine Whether the PTAB Engaged in Claim Construction In Google LLC…
January 2024 Federal Circuit Newsletter (Japanese) January 2024 Federal Circuit Newsletter (Chinese) Single Means Single In Pacific Biosciences Of California, Inc. v. Personal Genomics Taiwan, Inc., Appeal No. 22-1410,…
December 2023 Federal Circuit Newsletter (Japanese) December 2023 Federal Circuit Newsletter (Chinese) Intel Wrongly Denied Opportunity to Litigate License Defense that Could Unwind $2.1 Billion Judgment In Vlsi Technology…
November 2023 Federal Circuit Newsletter (Japanese) November 2023 Federal Circuit Newsletter (Chinese) Federal Circuit Orders District Court to Consider Extrinsic Evidence in Claim Construction In Actelion Pharmaceuticals Ltd. v….
